03860.HK
EPS Creative Health Technology Group Limited
HKSE · Consumer Cyclical · Apparel - Retail · HK
HKD 0.60
+9.09%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.0B | 457.6M | 544.5M | 644.6M | 452.9M |
| Cost of Revenue | 832.6M | 382.6M | 449.9M | 545.4M | 385.1M |
| Gross Profit | 169.6M | 75.0M | 94.6M | 99.3M | 67.8M |
| Operating Expenses | |||||
| R&D Expense | 18.1M | — | 18.1M | 24.3M | 13.0M |
| SG&A Expense | 159.2M | 74.2M | 84.9M | 103.8M | 96.9M |
| General & Admin Expense | 74.1M | 42.9M | 49.6M | 55.0M | 63.1M |
| Selling & Marketing Expense | 49.2M | 31.3M | 35.3M | 48.8M | 33.8M |
| Other Expenses | (50.2M) | — | (50.2M) | (11.9M) | 261.0K |
| Total Operating Expenses | 127.1M | 74.2M | 52.9M | 116.2M | 110.2M |
| Cost and Expenses | 959.7M | 456.9M | 502.8M | 661.6M | 494.2M |
| Operating Income (EBIT) | 42.5M | 773.0K | 41.7M | (17.0M) | (42.4M) |
| Non-Operating | |||||
| Interest Income | 663.0K | 125.0K | 538.0K | 1.1M | 190.0K |
| Interest Expense | 14.8M | 6.4M | 8.3M | 7.1M | 5.8M |
| Net Interest Income | (14.1M) | (6.3M) | (7.8M) | (6.0M) | (5.6M) |
| Other Non-Op Income/Expense | (16.6M) | (8.3M) | (8.3M) | (7.1M) | (5.8M) |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 25.9M | (7.5M) | 33.4M | (24.1M) | (48.2M) |
| Income Tax Expense | 6.5M | 3.5M | 3.0M | 2.4M | 2.1M |
| Bottom Line | |||||
| Net Income | 24.7M | (13.8M) | 38.6M | (22.1M) | (45.7M) |
| Earnings from Cont. Ops | 19.4M | (11.0M) | 30.4M | (26.5M) | (50.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 24.7M | (13.8M) | 38.6M | (22.1M) | (45.7M) |
| Per Share | |||||
| Basic EPS | HK$0.05 | (HK$0.03) | HK$0.07 | (HK$0.04) | (HK$0.09) |
| Diluted EPS | HK$0.05 | (HK$0.03) | HK$0.07 | (HK$0.04) | (HK$0.09) |
| Revenue Per Share | HK$1.92 | HK$0.88 | HK$1.05 | HK$1.29 | HK$0.91 |
| Shares | |||||
| Basic Shares Outstanding | 522.8M | 522.2M | 520.9M | 500.0M | 500.0M |
| Diluted Shares Outstanding | 522.8M | 522.2M | 520.9M | 500.0M | 500.0M |
| Profitability Metrics | |||||
| EBITDA | 73.7M | 17.6M | 57.5M | (3.0M) | (37.9M) |
| D&A | 31.2M | 16.9M | 15.8M | 14.0M | 4.5M |
| EBIT | 42.5M | 773.0K | 41.7M | (17.0M) | (42.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026